iDS – ME (often referred to as Al Ittihad Drug Store or IDS) is a leading pharmaceutical distributor and service provider based in the UAE. Established in 1987 and headquartered in Dubai, IDS has built a reputation as a comprehensive partner for hospitals, pharmacies, supermarkets, and healthcare institutions. The company’s portfolio features a wide array of essential pharmaceuticals and healthcare products, including treatments for diabetes, hypertension, oncology, and general wellbeing. With over 400 million AED in annual sales, IDS boasts one of the most extensive distribution networks in the region, serving more than 50 government hospitals, 80 private hospitals, 3,000 pharmacies, and hundreds of cooperatives and supermarkets.
IDS stands out for its complete integration of sales, marketing, logistics, customer service, and regulatory compliance, offering clients a “single source” solution for product registration, launch, promotion, and distribution in the UAE. The company’s logistics and customer service teams are supported by advanced delivery monitoring and automated systems, ensuring efficient and reliable supply chain operations. IDS’s regulatory experts help partners navigate UAE health regulations, ensuring full compliance with authorities like the MOH, HAAD, and DHA, which has made the company a preferred partner for both local and global healthcare principals.
A privately held part of GlobalOne Healthcare Holding (GHH), IDS leverages regional expertise and international standards to maintain its leadership in the sector. The company values a “customer-first” mindset and localized knowledge, tailoring its sales strategies to the evolving market. Regularly participating in institutional tenders and collaborating with governmental organizations such as SEHA and Dubai Health Authority, IDS continues to play a critical role in supporting the UAE’s healthcare ecosystem and strengthening community health outcomes.
